News report 📈 Stocks 🌍 United States ISIN US6311031081

Nasdaq Issues Routine Regulation SCI Operational Testing Notice

Nasdaq issued a routine operational notice regarding Regulation SCI BCP/DR testing across its suite of equity and options exchanges, maintaining standard regulatory compliance protocols.

🕐 1 min read

1 assets impacted (Stocks). Net bias: 0 Bullish, 0 Bearish, 1 Neutral. Strongest signal: NDAQ → 1/10 (70% confidence).

📊 Affected Assets (1)

NDAQ
Neutral 🤖 70%
📅 Short-term 🌍 US · Explicit

Nasdaq issued a routine reminder about Regulation SCI BCP/DR testing across its exchanges, which is a standard operational notice with no expected financial impact.

🎯 Key Takeaways

  • Nasdaq issued Equity Trader Alert #2026-060 for routine regulatory compliance.
  • The notice covers BCP/DR testing requirements under Regulation SCI.
  • Multiple exchanges including Nasdaq PHLX, ISE, and PSX are included in the scope.

📝 Executive Summary

Nasdaq has released Equity Trader Alert #2026-060, providing a standard operational reminder regarding Regulation SCI business continuity and disaster recovery testing. The notice covers multiple exchange platforms, including the Nasdaq Stock Market and various options exchanges, ensuring compliance with regulatory requirements.

❓ FAQ

What is the purpose of Nasdaq Equity Trader Alert #2026-060?

The alert serves as a routine operational reminder regarding mandatory Regulation SCI business continuity and disaster recovery testing across Nasdaq's exchange platforms.